Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy
出版年份 2021 全文链接
标题
Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy
作者
关键词
-
出版物
CANCER GENE THERAPY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-06-22
DOI
10.1038/s41417-021-00359-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer
- (2020) Yuxiang Li et al. CELLULAR IMMUNOLOGY
- Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors
- (2020) Caroline E. Porter et al. MOLECULAR THERAPY
- The therapeutic landscape for cells engineered with chimeric antigen receptors
- (2020) Matthew MacKay et al. NATURE BIOTECHNOLOGY
- Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells
- (2020) Leilei Zhang et al. Cell Death & Disease
- Recent advances of oncolytic virus in cancer therapy
- (2020) Moumita Mondal et al. Human Vaccines & Immunotherapeutics
- Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma
- (2020) Stefania Oliva et al. Frontiers in Oncology
- Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy
- (2020) Josephine Hai et al. CLINICAL CANCER RESEARCH
- Oncolytic Viruses for the Treatment of Metastatic Melanoma
- (2020) Megan H. Trager et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- An Update on the Role of Talimogene Laherparepvec (T-VEC) in the Treatment of Melanoma: Best Practices and Future Directions
- (2020) Cecilia A. Larocca et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Concise review on optimized methods in production and transduction of lentiviral vectors in order to facilitate immunotherapy and gene therapy
- (2020) Hadi Esmaeili Gouvarchin Ghaleh et al. BIOMEDICINE & PHARMACOTHERAPY
- Viral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy
- (2020) Amin Aalipour et al. Molecular Therapy-Oncolytics
- Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer
- (2020) Kotaro Sugawara et al. Molecular Therapy-Oncolytics
- Combination Therapy for Solid Tumors: Taking a Classic CAR on New Adventures
- (2020) Oula Dagher et al. CANCER CELL
- Adenovirus-mediated specific tumor tagging facilitates CAR-T therapy against antigen-mismatched solid tumors
- (2020) Xinying Tang et al. CANCER LETTERS
- Overcoming key challenges in cancer immunotherapy with engineered T cells
- (2020) Silvia Arcangeli et al. CURRENT OPINION IN ONCOLOGY
- Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection
- (2020) Lara Labarta-Bajo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The discovery and development of oncolytic viruses: are they the future of cancer immunotherapy?
- (2020) Shunchuan Zhang et al. Expert Opinion on Drug Discovery
- Chimeric Antigen Receptor T-cell (CAR T) Therapy for Hematologic and Solid Malignancies: Efficacy and Safety—A Systematic Review with Meta-Analysis
- (2019) Wen-Liang Yu et al. Cancers
- Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager
- (2019) Jana de Sostoa et al. Journal for ImmunoTherapy of Cancer
- The enhanced tumor specificity of TG6002, an armed-oncolytic vaccinia virus deleted in two genes involved in nucleotide metabolism
- (2019) Johann Foloppe et al. Molecular Therapy-Oncolytics
- Engineering and Design of Chimeric Antigen Receptors
- (2019) Sonia Guedan et al. Molecular Therapy-Methods & Clinical Development
- Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
- (2019) Mohamed-Reda Benmebarek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Using CuO nanoparticles and hyperthermia in radiotherapy of MCF-7 cell line: synergistic effect in cancer therapy
- (2019) Hadi Esmaeili Govarchin Ghaleh et al. Artificial Cells Nanomedicine and Biotechnology
- Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
- (2019) Stefan Stoiber et al. Cells
- Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies
- (2019) Lorraine Springuel et al. BIODRUGS
- HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases
- (2019) Steven C. Katz et al. CANCER GENE THERAPY
- Optimizing oncolytic virotherapy in cancer treatment
- (2019) Kevin Harrington et al. NATURE REVIEWS DRUG DISCOVERY
- Solid Tumors Challenges and New Insights of CAR T Cell Engineering
- (2019) Safa Tahmasebi et al. Stem Cell Reviews and Reports
- Myeloid immunosuppression and immune checkpoints in the tumor microenvironment
- (2019) Kyohei Nakamura et al. Cellular & Molecular Immunology
- Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches
- (2019) Maria Tagliamonte et al. CANCER LETTERS
- Current challenges and emerging opportunities of CAR-T cell therapies
- (2019) Teresa R. Abreu et al. JOURNAL OF CONTROLLED RELEASE
- The epidemiology of norovirus gastroenteritis in China: disease burden and distribution of genotypes
- (2019) Honglu Zhou et al. Frontiers of Medicine
- Generation of a Tumor-Specific Chemokine Gradient Using Oncolytic Vesicular Stomatitis Virus Encoding CXCL9
- (2019) Elizabeth C. Eckert et al. Molecular Therapy-Oncolytics
- Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
- (2018) Stephen J. Russell et al. CANCER CELL
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
- (2018) Kristian M. Hargadon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
- (2018) Jason Chesney et al. JOURNAL OF CLINICAL ONCOLOGY
- Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward
- (2018) Jian Li et al. Journal of Hematology & Oncology
- Superagonist IL-15-armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade
- (2018) Stacy J. Kowalsky et al. MOLECULAR THERAPY
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus–Driven Production of a Bispecific T-cell Engager
- (2018) Anna Wing et al. Cancer Immunology Research
- Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
- (2018) Giulia Marelli et al. Frontiers in Immunology
- Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines
- (2018) Edmund K. Moon et al. OncoImmunology
- TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade
- (2018) V. Cervera-Carrascon et al. OncoImmunology
- Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
- (2018) Carole Achard et al. EBioMedicine
- A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
- (2018) Devalingam Mahalingam et al. Cancers
- A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors
- (2018) Valerio Leoni et al. PLoS Pathogens
- Cytokines in clinical cancer immunotherapy
- (2018) Pedro Berraondo et al. BRITISH JOURNAL OF CANCER
- Abscopal Effect in Non-injected Tumors Achieved with Cytokine-Armed Oncolytic Adenovirus
- (2018) Riikka Havunen et al. Molecular Therapy-Oncolytics
- Enhanced Safety and Efficacy of Oncolytic VSV Therapy by Combination with T Cell Receptor Transgenic T Cells as Carriers
- (2018) Michael Karl Melzer et al. Molecular Therapy-Oncolytics
- Chimeric antigen receptor-T cell therapy for solid tumors require new clinical regimens
- (2017) Jinjing Xu et al. Expert Review of Anticancer Therapy
- Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus
- (2017) Nusrat Jahan et al. INTERNATIONAL JOURNAL OF CANCER
- Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models
- (2017) Shinichi Esaki et al. INTERNATIONAL JOURNAL OF CANCER
- High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients
- (2017) J Pan et al. LEUKEMIA
- Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma
- (2017) A Dispenzieri et al. LEUKEMIA
- Solid Tumor Immunotherapy with T Cell Engager-Armed Oncolytic Viruses
- (2017) Eleanor M. Scott et al. MACROMOLECULAR BIOSCIENCE
- Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA + Metastatic Colorectal Cancers
- (2017) Chengcheng Zhang et al. MOLECULAR THERAPY
- Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells
- (2017) Daniel T. MacLeod et al. MOLECULAR THERAPY
- Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy
- (2017) Nicholas M. Durham et al. MOLECULAR THERAPY
- Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer
- (2017) Amanda Rosewell Shaw et al. MOLECULAR THERAPY
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
- (2017) Terry J Fry et al. NATURE MEDICINE
- ATIM-08. IMMUNOMARKERS IN THE DNX-2401 (DELTA-24-RGD) ONCOLYTIC VIRUS PHASE I CLINICAL TRIAL
- (2017) Juan Fueyo et al. NEURO-ONCOLOGY
- Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
- (2017) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results
- (2017) Vignesh T. Packiam et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers
- (2017) Kaichao Feng et al. Protein & Cell
- Novel “Elements” of Immune Suppression within the Tumor Microenvironment
- (2017) Devikala Gurusamy et al. Cancer Immunology Research
- Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.
- (2017) Tiphaine Delaunay et al. OncoImmunology
- Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma
- (2017) Alena C. Jaime-Ramirez et al. Molecular Therapy-Oncolytics
- Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection
- (2017) Rocio Garcia-Carbonero et al. Journal for ImmunoTherapy of Cancer
- Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy
- (2016) Oladapo O. Yeku et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overview
- (2016) C. H. J. Lamers et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Innate immune signaling and regulation in cancer immunotherapy
- (2016) Leticia Corrales et al. CELL RESEARCH
- CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
- (2016) Cameron J. Turtle et al. JOURNAL OF CLINICAL INVESTIGATION
- Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
- (2016) Hanren Dai et al. JNCI-Journal of the National Cancer Institute
- Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
- (2016) Lenka V. Hurton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer
- (2016) Kaichao Feng et al. Science China-Life Sciences
- Oncolytic adenovirus expressing interleukin-18 improves antitumor activity of dacarbazine for malignant melanoma
- (2016) Chunhua Yang et al. Drug Design Development and Therapy
- A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases
- (2016) Xilin Chen et al. Oncotarget
- Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
- (2016) Hanren Dai et al. JNCI-Journal of the National Cancer Institute
- Clinical manufacturing of CAR T cells: foundation of a promising therapy
- (2016) Xiuyan Wang et al. Molecular Therapy-Oncolytics
- Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
- (2015) Zeguo Zhao et al. CANCER CELL
- Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy
- (2015) F. J. Kohlhapp et al. CLINICAL CANCER RESEARCH
- Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases
- (2015) S. C. Katz et al. CLINICAL CANCER RESEARCH
- Insertion of exogenous epitopes in the E3-19K of oncolytic adenoviruses to enhance TAP-independent presentation and immunogenicity
- (2015) A Rodríguez-García et al. GENE THERAPY
- Phase I/II safety and antitumor activity of nivolumab in patients with advanced hepatocellular carcinoma (HCC): CA209-040.
- (2015) Anthony B. El-Khoueiry et al. JOURNAL OF CLINICAL ONCOLOGY
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer
- (2015) Se Hoon Park et al. MOLECULAR THERAPY
- Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity
- (2015) Carolina S Ilkow et al. NATURE MEDICINE
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Suppression of cancer relapse and metastasis by inhibiting cancer stemness
- (2015) Youzhi Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
- (2015) E. Sotillo et al. Cancer Discovery
- Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer
- (2015) Manish R. Patel et al. Oncotarget
- Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor
- (2015) S. Tahtinen et al. Cancer Immunology Research
- Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
- (2015) Abhishek D. Garg et al. Frontiers in Immunology
- Are BiTEs the “missing link” in cancer therapy?
- (2015) Carter M Suryadevara et al. OncoImmunology
- CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
- (2015) Zuqiang Liu et al. OncoImmunology
- Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.
- (2015) Nabil Ahmed et al. Journal for ImmunoTherapy of Cancer
- Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy
- (2014) Fu-Liang Bai et al. CANCER BIOLOGY & THERAPY
- Armed Oncolytic Virus Enhances Immune Functions of Chimeric Antigen Receptor-Modified T Cells in Solid Tumors
- (2014) N. Nishio et al. CANCER RESEARCH
- Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor-Transduced Human T cells in Solid Tumors
- (2014) E. K. Moon et al. CLINICAL CANCER RESEARCH
- Vector Integration and Tumorigenesis
- (2014) Christof von Kalle et al. HUMAN GENE THERAPY
- CLINICAL TRIALS OF A THIRD-GENERATION RECOMBINANT ONCOLYTIC HSV-1 IN RECURRENT GLIOBLASTOMA AND OLFACTORY NEUROBLASTOMA PATIENTS
- (2014) T. Todo et al. NEURO-ONCOLOGY
- Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape
- (2014) A. C. Anderson Cancer Immunology Research
- Armed Therapeutic Viruses – A Disruptive Therapy on the Horizon of Cancer Immunotherapy
- (2014) Maxine Bauzon et al. Frontiers in Immunology
- Measles Virus Vaccine-Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells
- (2013) J.-B. Guillerme et al. CLINICAL CANCER RESEARCH
- How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?
- (2013) Walter H Meisen et al. Expert Review of Neurotherapeutics
- Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence
- (2013) Timothy Kottke et al. NATURE MEDICINE
- Immunodominance: A pivotal principle in host response to viral infections
- (2012) Ali Akram et al. CLINICAL IMMUNOLOGY
- Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses
- (2012) K-W Peng et al. GENE THERAPY
- The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
- (2012) Dennis Lindau et al. IMMUNOLOGY
- Enhanced antitumoral activity of oncolytic herpes simplex virus with gemcitabine using colorectal tumor models
- (2012) Shinichi Esaki et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Trial of Intravenous Administration of Reolysin® (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma
- (2012) Evanthia Galanis et al. MOLECULAR THERAPY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Clinical trials involving the oncolytic virus, reovirus: ready for prime time?
- (2012) Allison J Black et al. Expert Review of Clinical Pharmacology
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- TGF-β2 Signaling in High-Grade Gliomas
- (2011) Peter Hau et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα
- (2011) I-K Choi et al. GENE THERAPY
- Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine
- (2011) Nicole Frahm et al. JOURNAL OF CLINICAL INVESTIGATION
- Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
- (2010) H.-T. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interference of CD40L-Mediated Tumor Immunotherapy by Oncolytic Vesicular Stomatitis Virus
- (2009) Feorillo Galivo et al. HUMAN GENE THERAPY
- Measles Virus Induces Oncolysis of Mesothelioma Cells and Allows Dendritic Cells to Cross-Prime Tumor-Specific CD8 Response
- (2008) A. Gauvrit et al. CANCER RESEARCH
- Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM
- (2008) James M Markert et al. MOLECULAR THERAPY
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
- (2008) Martin A Pule et al. NATURE MEDICINE
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search